Guldiken Sibel, Demir Muzaffer, Arikan Ender, Turgut Burhan, Azcan Sennur, Gerenli Murat, Tugrul Armagan
Medical Faculty, Department of Endocrinology and Metabolism, Trakya University, 22030 Edirne, Turkey.
Thromb Res. 2007;119(1):79-84. doi: 10.1016/j.thromres.2005.12.019. Epub 2006 Feb 14.
It is well demonstrated that obesity is an independent risk factor for cardiovascular diseases. Recent studies have shown that obesity, insulin resistance and atherosclerosis are closely related phenomena in which low-grade inflammatory state and prothrombotic condition has pivotal roles. It has been shown that CD40-soluble CD40 ligand (sCD40L) interactions might constitute an important mediator for vascular inflammation. The aim of the present study was to assess sCD40L in relation to hs-CRP and cardiovascular risk factors in relation to body mass index (BMI).
Serum sCD40L and hs-CRP concentrations were measured in 52 obese patients and 28 non-obese subjects by ELISA. Insulin resistance was calculated by homeostasis model assessment-insulin resistance (HOMA-IR). We divided the participants into three groups depending in their BMI levels (Group 1: BMI <25 kg/m(2), Group 2: BMI 30-34.9 kg/m(2), Group 3: BMI > or =35 kg/m(2)).
We determined that the mean sCD40L of group 3 was significantly higher than group 1 and group 2 (p<0.05, p<0.05, respectively). However, there was no significant correlation between plasma sCD40L levels and BMI. Plasma levels of hs-CRP were higher in obese group than the non-obese group (p<0.001). The levels of sCD40L were not significantly different between the two groups. The mean hs-CRP levels increased gradually in accordance with groups of BMI, there was a strong correlation between hs-CRP levels and BMI (r=0.724, p<0.001). There was no significant correlation between sCD40L and hs-CRP levels in all participants.
It is still a subject for debate whether sCD40L levels are increased or not in obesity. However, the results of this study showed that sCD40L is substantially increased in patients with severe obesity. In terms of causality, the relatively small sample size and cross-sectional design of this study are considered to be the limitation factors.
大量研究表明,肥胖是心血管疾病的独立危险因素。近期研究显示,肥胖、胰岛素抵抗和动脉粥样硬化是密切相关的现象,其中低度炎症状态和血栓前状态起关键作用。研究表明,CD40-可溶性CD40配体(sCD40L)相互作用可能是血管炎症的重要介质。本研究旨在评估sCD40L与超敏C反应蛋白(hs-CRP)的关系,以及与体重指数(BMI)相关的心血管危险因素。
采用酶联免疫吸附测定法(ELISA)检测52例肥胖患者和28例非肥胖受试者血清中的sCD40L和hs-CRP浓度。通过稳态模型评估-胰岛素抵抗(HOMA-IR)计算胰岛素抵抗。根据BMI水平将参与者分为三组(第1组:BMI<25kg/m²,第2组:BMI 30-34.9kg/m²,第3组:BMI≥35kg/m²)。
我们发现第3组的平均sCD40L显著高于第1组和第2组(分别为p<0.05,p<0.05)。然而,血浆sCD40L水平与BMI之间无显著相关性。肥胖组的血浆hs-CRP水平高于非肥胖组(p<0.001)。两组之间的sCD40L水平无显著差异。hs-CRP的平均水平随BMI组别的增加而逐渐升高,hs-CRP水平与BMI之间存在强相关性(r=0.724,p<0.001)。所有参与者中,sCD40L与hs-CRP水平之间无显著相关性。
肥胖时sCD40L水平是否升高仍存在争议。然而,本研究结果表明,重度肥胖患者的sCD40L显著升高。就因果关系而言,本研究相对较小的样本量和横断面设计被认为是限制因素。